HOYA Co. (OTCMKTS:HOCPY - Get Free Report) saw a significant increase in short interest in the month of May. As of May 15th, there was short interest totalling 15,500 shares, an increase of 167.2% from the April 30th total of 5,800 shares. Based on an average daily volume of 69,900 shares, the short-interest ratio is presently 0.2 days. Currently, 0.0% of the company's shares are short sold.
Analyst Ratings Changes
Separately, Erste Group Bank upgraded HOYA from a "hold" rating to a "strong-buy" rating in a report on Friday, May 23rd.
View Our Latest Report on HOCPY
HOYA Trading Down 3.4%
Shares of HOCPY stock traded down $4.09 on Monday, hitting $116.98. The company had a trading volume of 116,843 shares, compared to its average volume of 38,135. HOYA has a twelve month low of $97.49 and a twelve month high of $148.27. The company has a debt-to-equity ratio of 0.02, a quick ratio of 4.35 and a current ratio of 5.04. The firm has a market cap of $40.14 billion, a P/E ratio of 29.77, a P/E/G ratio of 2.38 and a beta of 0.93. The stock's 50-day moving average is $115.93 and its two-hundred day moving average is $122.78.
HOYA (OTCMKTS:HOCPY - Get Free Report) last announced its earnings results on Thursday, May 1st. The technology company reported $0.98 EPS for the quarter, missing the consensus estimate of $0.99 by ($0.01). HOYA had a net margin of 24.17% and a return on equity of 21.34%. The company had revenue of $1.52 billion during the quarter, compared to the consensus estimate of $1.50 billion. On average, equities research analysts anticipate that HOYA will post 3.66 earnings per share for the current fiscal year.
About HOYA
(
Get Free Report)
HOYA Corporation, a med-tech company, provides high-tech and medical products worldwide. It operates through three segments: Life Care, Telecommunication, and Other. The company offers life care products, including eyeglass and contact lenses; medical endoscopes; intraocular lenses; laparoscopic surgical instruments; automatic endoscope cleaning equipment; and other medical related products, such as prosthetic ceramic fillers and metallic implants for orthopedics.
Read More
Before you consider Hoya, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Hoya wasn't on the list.
While Hoya currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
